Medical News

RSS

Securing universal access to HIV prevention, care, treatment and support

The biennial meeting of the global AIDS community concluded today with clear evidence of tangible progress in HIV research and programme scale up, yet facing an urgent need for increased resources, the protection of human rights, and broader use of scientifically sound prevention strategies. Delegates and organizers depart Vienna - where the conference opened 18 July under the theme of Rights Here, Right Now -- with a renewed commitment to push for securing universal access to HIV prevention, care, treatment and support.

23 Jul 2010

Today's OpEds: Varying points on the nation's doctor shortage, benefits of negative studies, and what about universal health care?

In the long list of problems affecting the American health care system, the shortage of general practitioners and overabundance of specialists is usually ranked near the top. There is truth to this: only 32 percent of physicians practice primary care medicine. As a result, patients have to wait longer to see their doctors and are more likely to be seen by nurse practitioners and physician assistants instead. However, pediatrics has the opposite problem: a growing shortage of pediatric subspecialists (Dennis Rosen, 7/22).

23 Jul 2010

Researchers investigate regional variation in Medicare spending

In the latest Health Policy Outlook from the American Enterprise Institute and the Schaeffer Center for Health Policy and Economics at USC, Schaeffer Center researchers investigated whether geographic variations in utilization of health services and spending differed between Medicare and the private sector.

23 Jul 2010

First generic version of Lovenox receives FDA approval for DVT

The U.S. Food and Drug Administration today approved the first generic version of Lovenox (enoxaparin sodium injection), an anti-coagulant drug used to prevent deep vein thrombosis, a potentially deadly blood clotting condition.

23 Jul 2010

NYC hospitals agree to pilot program to cut medical-malpractice costs

To cut medical-malpractice costs, five New York City hospitals have agreed to a pilot program to divulge medical mistakes early, offer settlements quickly and use special state 'health courts,' where judges will help negotiate agreements before cases go to trial. The program, funded for three years with $3 million from the federal government, aims to cut the $1.4 billion spent annually in New York State on medical-malpractice premiums, hospital and state officials say.

23 Jul 2010

HPM recognizes 19 Michigan health care providers for outstanding quality, service

The 19 Michigan health care providers were identified as the top primary care offices through a rigorous selection process that was based on Health Plan of Michigan's 2009 quality incentive plan. "We wanted to show our gratitude to our highest ranking health care providers for their excellence in quality and service," said Raymond D. Pitera, Vice President of Provider Service for Health Plan of Michigan. "We truly appreciate the access to quality services they provide to our Medicaid Members."

23 Jul 2010

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

Unigene Laboratories, Inc. today noted that Tarsa Therapeutics has completed patient enrollment in the Phase III ORACAL trial of Tarsa's oral calcitonin product for the treatment of postmenopausal osteoporosis. Unigene licensed the product to Tarsa and owns 26% of the company.

23 Jul 2010

GRB7 gene drives an aggressive form of breast cancer, researchers find

Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis.

23 Jul 2010

GOP questions math of HHS' premium hike estimates; Abortion issue defining implementation

Senate Republican leaders are questioning an estimate by the Department of Health and Human Services that the effect of the new health law on insurance premiums will likely be less than 1 percent, The Hill reports.

23 Jul 2010

China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal Suppositories

China Sky One Medical, Inc., a leading fully integrated pharmaceutical company in the People's Republic of China, today announced that the Company has obtained approval from the State Food and Drug Administration in China for the production of Ciclopirox Olamine Vaginal Suppositories.

23 Jul 2010

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

Abraxis BioScience, Inc., a fully integrated, global biotechnology company, today announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer. The New Drug Application (J-NDA) for ABRAXANE was filed with the Ministry of Health, Labor and Welfare in 2008.

23 Jul 2010

States still hoping for extra Medicaid money but also developing contingency plans

Kaiser Health News reports that states and hospital groups continue to lobby for a six-month extension of enhanced Medicaid money despite funding concerns and the lack of a way forward for such an extension.

23 Jul 2010

Most Americans with disabilities still struggle with lifestyle, economic issues: Survey

On the 20th anniversary of the signing of the Americans with Disabilities Act, a new survey sponsored by Kessler Foundation and National Organization on Disability finds that most Americans with disabilities are still struggling with many of the same lifestyle and economic issues they confronted in 1990 when the ADA became federal law.

23 Jul 2010

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

XenoPort, Inc. announced today that it has discovered a novel prodrug that has the potential to improve significantly the blood concentration of acamprosate compared with the currently approved formulation of acamprosate. Preclinical data on this new product candidate will be presented tomorrow at the National Fragile X Foundation's 12th International Fragile X Conference in Detroit, Michigan.

23 Jul 2010

MAXIMUS operates health care appeal programs for state regulatory agencies

The United States Departments of Health and Human Services, Labor and the Treasury announced yesterday a new internal claims and appeals and external review process for group health plans under the Patient Protection and Affordable Care Act.

23 Jul 2010

CRF Health collects prestigious IPA Best of Health Awards

CRF Health garnered nine awards recently in the Business-to-Business categories of the Institute of Practitioners in Advertising Best of Health Awards, for their bold, new communications aimed at healthcare professionals involved in clinical trials. The awards were collected by their creative agency behind the campaign, Langland, at the awards night in London.

23 Jul 2010

Applications accepted for September 2010 CMPP examination

Applications are now being accepted for the September 2010 Certified Medical Publication Professional examination. Qualified candidates can take the three-hour exam during the September 1-30, 2010 testing window at approved locations around the globe.

23 Jul 2010

Renhuang awarded AAA(1) rating

Renhuang Pharmaceuticals, Inc., a developer, manufacturer and distributor of botanical products, bio-pharmaceuticals and traditional Chinese medicines, today announced that the Company was recently awarded an AAA(1) rating by Chinese Academy of International Trade & Economic Cooperation of Ministry of Commerce.

23 Jul 2010

Titan anticipates second-quarter Fanapt royalty payment of $55,000

Titan Pharmaceuticals, Inc. today reported that the company expects to receive a royalty payment of approximately $55,000 on second quarter 2010 sales of Fanapt (iloperidone) of approximately $693,000. This reflects a significant decrease from first quarter sales which, as is customary, included substantial initial product stocking in the distribution channels.

23 Jul 2010

IPC signs agreement with UCSF to develop leadership training program for physician managers

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has entered into an agreement with the University of California, San Francisco Division of Hospital Medicine and its Center for the Health Professions to develop a leadership training program for dozens of IPC's key physician managers.

23 Jul 2010

Medical News

Securing universal access to HIV prevention, care, treatment and support

Today's OpEds: Varying points on the nation's doctor shortage, benefits of negative studies, and what about universal health care?

Researchers investigate regional variation in Medicare spending

First generic version of Lovenox receives FDA approval for DVT

NYC hospitals agree to pilot program to cut medical-malpractice costs

HPM recognizes 19 Michigan health care providers for outstanding quality, service

Tarsa Therapeutics completes patient enrollment in Phase III ORACAL trial of oral calcitonin

GRB7 gene drives an aggressive form of breast cancer, researchers find

GOP questions math of HHS' premium hike estimates; Abortion issue defining implementation

China Sky One Medical receives SFDA approval for producing Ciclopirox Olamine Vaginal Suppositories

Taiho Pharmaceutical receives approval to market ABRAXANE IV Infusion 100 mg in Japan

States still hoping for extra Medicaid money but also developing contingency plans

Most Americans with disabilities still struggle with lifestyle, economic issues: Survey

Preclinical data of new acamprosate prodrug to be presented at International Fragile X Conference

MAXIMUS operates health care appeal programs for state regulatory agencies

CRF Health collects prestigious IPA Best of Health Awards

Applications accepted for September 2010 CMPP examination

Renhuang awarded AAA(1) rating

Titan anticipates second-quarter Fanapt royalty payment of $55,000

IPC signs agreement with UCSF to develop leadership training program for physician managers

Todd Bauman and Chris Povich

Scaling organ‑chip technology for human‑relevant drug discovery

Unlocking drug amorphization: Continuous, solvent-free twin screw granulation

Latest News